Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IKT
IKT logo

IKT Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Inhibikase Therapeutics Inc (IKT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.050
1 Day change
3.54%
52 Week Range
2.260
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

IKT is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The chart is technically constructive, but the lack of news, no clear bullish proprietary signal, no valuation support, and no visible financial snapshot make it too weak for a confident long-term purchase at the current price. If you want immediate action, this is not the strongest entry.

Technical Analysis

Technically, IKT is in a short-term bullish structure with SMA_5 > SMA_20 > SMA_200, which supports upward trend strength. MACD histogram is positive at 0.0296, though it is contracting, so momentum is still positive but fading. RSI_6 is 70.809, suggesting the stock is near overbought levels even if the system labels it neutral. Price closed at 1.95, below the previous close of 1.99, and sits just above pivot support at 1.908, with resistance at 2.059 and 2.152. Overall, the trend is positive but stretched and not ideal for an impatient long-term entry.

Positive Catalysts

  • No news was reported in the past week, so there are no clear event-driven catalysts. Technical trend remains bullish on moving averages, and the stock is holding near pivot support. AI Stock Pick: no signal on given stock today. SwingMax: No signal on given stock recently.

Neutral/Negative Catalysts

  • No recent news means no fresh catalyst to re-rate the stock. Hedge funds are neutral and insiders are neutral, showing no strong accumulation signal. The stock trend model suggests downside risk over multiple horizons, with estimated moves of -0.87% next day, -1.49% next week, and -7.5% next month. Post-market change of -2.01% also weakens near-term momentum.

Financial Performance

No usable latest-quarter financial snapshot was provided because of a data error, so there is no reliable way to assess the most recent quarterly growth trends or season from the supplied data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data was provided, so the recent trend in Wall Street ratings and target changes cannot be confirmed. Based on the available information, Wall Street appears neutral rather than strongly bullish, with no visible upgrade cycle or target increase trend. Pro view: the technical setup is acceptable. Con view: no news, no institutional/insider buying, no financial confirmation, and no proprietary buy signal.

Wall Street analysts forecast IKT stock price to rise
5 Analyst Rating
Wall Street analysts forecast IKT stock price to rise
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 1.980
sliders
Low
4
Averages
6.2
High
8
Current: 1.980
sliders
Low
4
Averages
6.2
High
8
Ladenburg
NULL -> Buy
initiated
$4
AI Analysis
2026-03-04
Reason
Ladenburg
Price Target
$4
AI Analysis
2026-03-04
initiated
NULL -> Buy
Reason
Ladenburg initiated coverage of Inhibikase Therapeutics with a Buy rating and $4 price target. The firm views Inhibikase's TKI imatinib approach in pulmonary arterial hypertension as "de-risked." IKT-001 is a remodeled prodrug version of imatinib specifically designed to improve tolerability, "thereby enabling successful use in PAH," the analyst tells investors in a research note.
Ladenburg
NULL -> Buy
initiated
$4
2026-03-04
Reason
Ladenburg
Price Target
$4
2026-03-04
initiated
NULL -> Buy
Reason
Ladenburg initiated coverage of Inhibikase Therapeutics with a Buy rating and $4 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for IKT
Unlock Now

People Also Watch